作者: B. J. Kennedy , A. Sigrid Gilbertsen
DOI: 10.1056/NEJM195704182561601
关键词: Erythropoiesis 、 Medicine 、 Internal medicine 、 Hemoglobin 、 Hormone therapy 、 Hormone 、 Endocrinology 、 Hyperplasia 、 Bone marrow 、 Cancer 、 Hematocrit 、 General Medicine
摘要: THE administration of androgenic hormones to women with advanced breast cancer has been associated an unusual alteration in erythropoietic activity.1 2 3 4 5 6 7 8 9 10 This consisted increases hemoglobin, red-cell count and hematocrit, hyperplasia the erythroid elements bone marrow. The increase activity is accompanied by clinical symptoms signs characteristic polycythemia. observations suggest that are a specific stimulating factor erythropoiesis and, when administered massive doses over prolonged period, will polycythemic level.10 Investigators hormone therapy have aware . . .